Quantitative Studies of Urinary Bladder Sensation
2 other identifiers
observational
60
1 country
1
Brief Summary
The purpose of this study is to determine whether more than one subpopulation exists of patients with the diagnosis of Interstitial Cystitis (IC) based on sensory testing and to determine if subjects with IC have normal counterirritation-related modulatory systems.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2007
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2007
CompletedFirst Submitted
Initial submission to the registry
April 23, 2009
CompletedFirst Posted
Study publicly available on registry
May 18, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2009
CompletedDecember 1, 2011
November 1, 2011
2.5 years
April 23, 2009
November 30, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The study proposes to examine the sensations that are produced by warming the skin, poking the skin, pressure on the muscles or by applying a blood pressure cuff.
One and a half to two hours
Interventions
No therapeutic intervention will be given. Quantitative Sensory Testing, thermal/mechanical/ischemic stimulus will be performed.
Eligibility Criteria
Non-healthy subjects will be recruited from Kirklin Clinic Urology Clinic and Pain Treatment Center. Healthy subjects will be recruited via advertisements.
You may qualify if:
- Must be able to read and speak English
- years or older
- IC Diagnosis
You may not qualify if:
- Over 65 years old
- Pregnant
- Children younger than 19
- Significant cardiac disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UAB Kirklin Clinic
Birmingham, Alabama, 35294, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Timothy Ness, M.D., Ph.D.
University of Alabama at Birmingham
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- M.D., Ph.D.
Study Record Dates
First Submitted
April 23, 2009
First Posted
May 18, 2009
Study Start
May 1, 2007
Primary Completion
November 1, 2009
Study Completion
November 1, 2009
Last Updated
December 1, 2011
Record last verified: 2011-11